Balyasny Asset Management LLC Alkermes Plc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $10.9 Million - $12.8 Million	-468,182 Reduced 97.2%	13,474 $324,000
Q1 2024 May 13, 2024	BUY	$26.4 - $32.56 $12.3 Million - $15.2 Million	465,372 Added 2857.85%	481,656 $13 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $79,551 - $97,626	3,404 Added 26.43%	16,284 $451,000
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $349,949 - $411,773	12,880 New	12,880 $360,000
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $24.7 Million - $28.3 Million	-976,880 Reduced 55.41%	786,067 $22.2 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $38.7 Million - $46.3 Million	1,762,947 New	1,762,947 $46.1 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $5.31 Million - $6.14 Million	-201,184 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $4.64 Million - $5.63 Million	201,184 New	201,184 $5.29 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $3.45 Million - $5.16 Million	-160,833 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $3.76 Million - $5.17 Million	160,833 New	160,833 $4.96 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $9.98 Million - $13.4 Million	-531,625 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $9.68 Million - $12.3 Million	531,625 New	531,625 $9.93 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $3.89 Million - $6.33 Million	-297,904 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $1.54 Million - $1.94 Million	89,175 Added 42.72%	297,904 $6.08 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $3.05 Million - $3.79 Million	156,216 Added 297.48%	208,729 $4.07 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $790,289 - $1.37 Million	36,809 Added 234.39%	52,513 $1.18 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $445,993 - $573,038	15,704 New	15,704 $573,000
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $3.05 Million - $3.87 Million	-75,268 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $4.04 Million - $5.06 Million	75,268 New	75,268 $4.36 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$865 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$564 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$386 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$376 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$273 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account